Summary
We zoom in on what the EU AI Act means for Danish pharma companies' communication with HCPs and patients, and what new compliance requirements it entails. We review the responsibility for the input & output created with AI and the duty to disclose AI-generated content. We also review dilemmas in specific cases on the use of AI in marketing and education of healthcare professionals and patients, so that you can use AI responsibly and compliantly in your daily work.
|
Key words
- New EU AI Act
- AI in pharma marketing
- HCP education
Save information for later
Course leader & lecturers
- Elisabeth Gammelgaard LudvigCourse leaderOwner
Sundhedsagenda - Christian Vinding ThomsenLecturerPartner og Advokat
Loeven Advokatfirma
Is this course for you?
- Brand manager
- Key account manager
- Marketing manager
- Medical affairs manager
- Promotional compliance manager
What you will learn
- Get a simple overview of the EU's AI ACT and what it means for pharmaceutical companies
- Learn how to use AI compliantly in communication and marketing
- See concrete cases and discuss dilemmas for using AI responsibly in your daily work
What your company will get
- An employee, who stays ahead of AI regulation rather than reacting to it.
- An employee, who develops good practical AI usage judgment through real use cases and dilemma discussions
Course calendar
Online session
- Summary of the EU AI Regulation and the importance of the disclosure obligation for pharma companies
- Who is responsible for AI-generated content and the interaction of healthcare professionals and patients with it?
- Discussion of cases
- Questions & answers
Course information
Literature
Prerequisites
A minimum of 1 year of industry experience is recommended
Examination
There is no examination for this course.
Course leader
Sundhedsagenda
Lecturer
Loeven Advokatfirma
Want to know more, or need help?
Contact Client Manager Laura Enemark Skyum at
+45 40 46 58 98 or lsk@atriumcph.com
